| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Natera, Inc. Common Stock | $32.0b | $215.14 | -3.1% | 849.5K | |
| Illumina Inc | $24.7b | $162.31 | -3.4% | 2.1M | |
| Labcorp Holdings Inc. | $21.3b | $265.15 | +1.6% | 429.3K | |
| QIAGEN N.V. | $7.5b | $36.68 | -2.3% | 1.4M | |
| BillionToOne, Inc. Class A Common Stock | $4.6b | $97.15 | -7.1% | 879.5K | |
| Veracyte, Inc. | $3.7b | $48.74 | -2.4% | 1.2M | |
| 10x Genomics, Inc. Class A Common Stock | $3.6b | $31.05 | -7.3% | 3.8M | |
| GeneDx Holdings Corp. Class A Common Stock | $1.5b | $52.28 | -7.1% | 1.2M | |
| NeoGenomics, Inc. | $1.4b | $10.90 | -3.6% | 1.0M | |
| Personalis, Inc. Common Stock | $1.2b | $10.73 | -11.3% | 4.1M | |
| CareDx, Inc. | $1.2b | $22.27 | -3.7% | 548.4K | |
| Opko Health Inc. | $1.1b | $1.43 | -2.0% | 3.9M | |
| Azenta, Inc. | $1.1b | $22.70 | -0.6% | 1.1M | |
| Mesa Laboratories Inc | $0.6b | $104.08 | -4.6% | 218.1K | |
| Fulgent Genetics, Inc. Common Stock | $0.5b | $19.14 | -1.9% | 375.0K | |
| Pacific Biosciences of California, Inc. | $462.8m | $1.45 | -11.3% | 6.5M | |
| Myriad Genetics Inc | $375.0m | $4.58 | -2.4% | 1.2M | |
| Prenetics Global Limited Class A Ordinary Share | $358.7m | $19.87 | -4.4% | 197.6K | |
| Insight Molecular Diagnostics Inc. Common Stock | $200.5m | $5.26 | -19.7% | 292.2K | |
| ALPS Group Inc Ordinary Share | $126.4m | $0.68 | -2.9% | 228.3K | |
| Quantum Cyber N.V. Ordinary Shares | $58.3m | $2.17 | -6.9% | 1.9M | |
| Bionano Genomics, Inc. Common Stock | $14.2m | $1.18 | -6.8% | 212.4K | |
| BioNexus Gene Lab Corp Common stock | $5.6m | $2.21 | -3.7% | 5.4K |